Tasly Biopharma will treat all your adverse event reports strictly in accordance with the current Chinese regulations. In order to further collect information about adverse events, Pharmacovigilance Department of Tasly Biopharma may conduct follow-up visits. We will keep all personal information and medical materials provided by you strictly confidential. Except for requirements from government regulatory authorities or laws and regulations, we will not disclose them to any other third parties.